Advertisement

Topics

‘Things Must Be Bad’: Mylan’s Stumbles Over Generic Drugs Indicative Of Larger Industry Trouble

09:31 EDT 10 Aug 2017 | Kaiser Health News

The company is the latest to slash their forecast due to generic drugs.

Original Article: ‘Things Must Be Bad’: Mylan’s Stumbles Over Generic Drugs Indicative Of Larger Industry Trouble

NEXT ARTICLE

More From BioPortfolio on "‘Things Must Be Bad’: Mylan’s Stumbles Over Generic Drugs Indicative Of Larger Industry Trouble"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...